Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia

Leukemia

Volumn 16, Issue 7, 2002, Pages 1285-1292

  Nishii, K ^a   Katayama, N ^a   Miwa, H ^b   Shikami, M ^b   Usui, E ^a   Masuya, M ^a   Araki, H ^a   Lorenzo, F ^a   Ogawa, T ^c   Kyo, T ^d   Nasu, K ^e   Shiku, H ^a   Kita, K ^f  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ASTELLAS PHARMA INC   (Japan)

^d ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^e OSAKA RED CROSS HOSPITAL   (Japan)

^f Tokura Hospital   (Japan)

Author keywords

Acute lymphoblastic leukemia; Apoptosis; Ikaros; RNA splicing; Transcription factor

Indexed keywords

CD19 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA; IKAROS TRANSCRIPTION FACTOR; ISOPROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BONE MARROW CELL; CANCER CELL CULTURE; CELL CULTURE; CELL NUCLEUS; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA CELL; MOUSE MUTANT; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROLYMPHOCYTE; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0036045383     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402533     Document Type: Article

References (32)

1. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP
2. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP
3. Failure of B-cell differentiation in mice lacking the transcription factor EBF
4. The helix-loop-helix gene E2A is required for B cell formation
5. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
6. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter
7. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment
8. RAG-1-deficient mice have no mature B and T lymphocytes
9. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D) J rearrangement
10. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins
11. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma
12. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes
13. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia
14. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia
15. Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: Association with the expression of bcl-2 protein
16. Immunologic classification of leukemia and lymphoma
17. Expression of B-cell associated transcription factors in precursor B-cell acute lymphoblastic leukemia cells: Association with PU.1 expression, phenotype, and immunogenotype
18. Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification
19. Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors
20. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse
21. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation
22. Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality
23. Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia
24. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development
25. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia
26. Cutting edge: Predominant expression of a novel Ikaros isoform in normal human hemopoiesis
27. Dissecting the pathway to death
28. Molecular signals in anti-apoptotic pathways
29. The Ikaros gene is required for the development of all lymphoid lineages
30. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia
31. Molecular genetics, natural history and the demise of childhood leukaemia
32. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero